Drug Of Abuse Testing Market Report 2026

Drug Of Abuse Testing Market Overview

• Drug Of Abuse Testing market size has reached to $7.16 billion in 2025 • Expected to grow to $9.97 billion in 2030 at a compound annual growth rate (CAGR) of 6.9% • Growth Driver: Prevalence Of Substance Abuse And Addiction Cases Fueling The Growth Of The Market Due To Rising Drug Use Disorder Burden • Market Trend: Next-Generation Technology Streamlines Comprehensive Drug Screening • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Drug Of Abuse Testing Market?

Drug of abuse testing is a scientific and systematic process used to detect and measure the presence of substances that can alter mood, perception, or behavior in biological specimens. It involves careful analysis of samples to accurately identify the presence of illicit, controlled, or potentially harmful drugs. It is essential for monitoring substance use patterns, supporting medical evaluations, and enhancing the understanding of the effects of these substances on individuals and communities. The main product and services of drug of abuse testing include rapid testing devices, urine testing devices, oral fluid saliva testing devices, analyzers, consumables, and laboratory services. Rapid testing devices refer to diagnostic tools that provide quick detection of drugs in biological samples for screening purposes. These products and services are utilized for sample types including urine, oral fluid saliva, hair, breath, blood, and sweat and are used for drug types such as psychostimulants, narcotics, cannabinoids, sedatives, and other drug types. They are performed using technique types including immunoassay, chromatography, and rapid testing, and they are used by several end users such as hospitals, diagnostic laboratories, forensic laboratories, and other end users.

What Is The Drug Of Abuse Testing Market Growth Forecast?

The drug of abuse testing market size is expected to see strong growth in the next few years.It will grow to $9.97 billion by 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to rising substance abuse monitoring initiatives, expansion of mandatory workplace testing policies, increased adoption of rapid point of care testing kits, growing forensic and criminal investigation demand, expansion of global rehabilitation and treatment programs.Major trends in the forecast period include Point of care rapid drug screening adoption, workplace drug testing compliance expansion, forensic toxicology laboratory specialization growth, sports and athletic anti-doping testing programs, emergency department toxicology screening protocols.

Global Drug Of Abuse Testing Market Segmentation

1) By Product And Service: Rapid Testing Devices, Urine Testing Devices, Oral Fluid Saliva Testing Devices, Analyzers, Consumables, Laboratory Services 2) By Sample Type: Urine, Oral Fluid Saliva, Hair, Breath, Blood, Sweat 3) By Drug Type: Psychostimulants, Narcotics, Cannabinoids, Sedatives, Other Drug Types 4) By Technique Type: Immunoassay, Chromatography 5) By End User: Hospitals, Diagnostic Laboratories, Forensic Laboratories, Other End Users Subsegments: 1) By Rapid Testing Devices: Point Of Care Testing Kits, Home Testing Kits, Immunoassay Rapid Test Strips, Portable Screening Devices 2) By Urine Testing Devices: Urine Collection Kits, Urine Screening Test Strips, Cup Based Testing Devices, Laboratory Urine Test Kits 3) By Oral Fluid Saliva Testing Devices: Saliva Collection Kits, Oral Fluid Screening Devices, Disposable Oral Swab Kits, Portable Saliva Analyzers 4) By Analyzers: Immunoassay Analyzers, Chromatography Analyzers, Mass Spectrometry Analyzers, Point Of Care Analyzers 5) By Consumables: Test Strips And Reagents, Sample Collection Tubes, Control And Calibration Kits, Disposable Pipettes And Swabs 6) By Laboratory Services: Drug Screening Services, Confirmatory Testing Services, Sample Collection And Processing Services, Data Reporting And Analysis Services

What Is The Driver Of The Drug Of Abuse Testing Market?

The rising prevalence of substance abuse and addiction is expected to propel the growth of the drug of abuse testing industry going forward.Substance abuse and addiction refer to the harmful or hazardous use of psychoactive substances, including illicit drugs and prescription medications, which can impair health, safety, and social or legal functioning.The prevalence of substance abuse and addiction is growing due to easier access to drugs and changing social behaviors that normalize or increase drug use.Drug of abuse testing helps address substance abuse and addiction by enabling early detection of drug use, guiding timely medical interventions, monitoring recovery progress, and supporting public health strategies to reduce the harmful impact of substance misuse.For instance, in December 2025, according to the Addiction Policy Forum, a US-based non-profit organization, Of the 48.4 million people with a substance use disorder, 27.9 million had an alcohol use disorder and 28.2 million had a drug use disorder in 2024.Therefore, the rising prevalence of substance abuse and addiction is driving the growth of the drug of abuse testing industry.

Key Players In The Global Drug Of Abuse Testing Market

Major companies operating in the drug of abuse testing market are F. Hoffmann‑La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Drägerwerk AG & Co. KGaA, Shimadzu Corporation, Bio‑Rad Laboratories Inc., OraSure Technologies, Clinical Reference Laboratory (CRL) Inc., Legacy Medical Services, Intoximeters Inc., Cordant Health Solutions, DrugScan, Premier Biotech Inc., UCP Biosciences, American Screening Corporation Inc., SureHire Inc.

Global Drug Of Abuse Testing Market Trends and Insights

Major companies operating in the drug of abuse testing market are focusing on developing advanced products such as, multi-analyte clinical drug testing panels to enable faster, more accurate, and comprehensive detection of multiple drugs simultaneously. Multi-analyte clinical drug testing panels are devices that simultaneously detect multiple drugs of abuse from a single sample, helping healthcare and forensic professionals quickly identify substance use with high accuracy and efficiency compared to traditional single-drug tests. For instance, in February 2026, Randox USA, a U. S. -based diagnostics company, received 510(k) clearance from the U. S. Food and Drug Administration (FDA) for its Evidence MultiSTAT, an innovative multi-analyte clinical drug testing panel. The device is a fully automated, cartridge-based analyzer that uses patented Biochip Technology to simultaneously detect 15 drugs of abuse from urine in just 21 minutes. It features a simple three-step testing process, pre-filled reagent cartridges, and delivers results with high accuracy comparable to confirmatory laboratory methods. The Evidence MultiSTAT covers a wide range of drug classes, including opioids, fentanyl, methamphetamine, cocaine, benzodiazepines, and cannabinoids, making it suitable for use in hospital laboratories, emergency departments, pain management clinics, behavioral health centers, and forensic settings. This technology improves efficiency, reduces human error, and provides rapid, reliable results compared to traditional single-analyte tests.

What Are Latest Mergers And Acquisitions In The Drug Of Abuse Testing Market?

In October 2025, Archimed Diagnostics, a France-based healthcare technology company, acquired Ark Diagnostics for an undisclosed amount. With this acquisition, Archimed Diagnostics aims to bolster its position in the in vitro diagnostics market by integrating Ark's expertise in rapid diagnostic tests, enhancing its product portfolio with innovative, high-performance solutions for infectious disease detection and point-of-care testing. Ark Diagnostics is a US-based healthcare technology company that specializes in providing drugs of abuse (DoA) testing solutions.

Regional Insights

North America was the largest region in the drug of abuse testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Drug Of Abuse Testing Market?

The drug of abuse testing market includes revenues earned by entities by providing services such as laboratory testing, specimen collection, sample transportation, result interpretation, clinical consultation, workplace drug screening, forensic analysis, point-of-care testing, confirmatory testing, counseling and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

What is the Market Assessment and Strategic Outlook for the Drug Of Abuse Testing Industry?

The drug of abuse testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the drug of abuse testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

What is the Market Assessment and Strategic Outlook for the Drug Of Abuse Testing Market Report 2026?

The drug of abuse testing market research report is one of a series of new reports from The Business Research Company that provides drug of abuse testing market statistics, including drug of abuse testing industry global market size, regional shares, competitors with a drug of abuse testing market share, detailed drug of abuse testing market segments, market trends and opportunities, and any further data you may need to thrive in the drug of abuse testing industry. This drug of abuse testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.